Bharat Biocon Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.77 M
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -7.66%
- Profit Growth 66.01%
- Ebitda 40.15%
- Net Worth -0.16%
- Total Assets -0.08%
About Bharat Biocon
Bharat Biocon Private Limited (BBPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 April 2010 and has a history of 14 years and nine months. Its registered office is in Raigarh, Chattisgarh, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.77 M, as per Ministry of Corporate Affairs (MCA) records.
Bharat Agrawal and Renu Agrawal serve as directors at the Company.
Company Details
-
Location
Raigarh, Chattisgarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100CT2010PTC001938
-
Company No.
001938
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Apr 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chhattisgarh
Industry
What products or services does Bharat Biocon Private Limited offer?
Bharat Biocon Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Biocides, Insecticides and Pesticides, Biofungicides, Fungicides, Fertilizers and Soil Additives, Nitrogen Fertilizers, Bio Fertilizers, Bio Insecticides.
Who are the key members and board of directors at Bharat Biocon?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bharat Agrawal | Director | 26-Apr-2010 | Current |
Renu Agrawal | Director | 26-Apr-2010 | Current |
Financial Performance of Bharat Biocon.
Bharat Biocon Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 7.66% decrease. The company also saw a substantial improvement in profitability, with a 66.01% increase in profit. The company's net worth dipped by a decrease of 0.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Bharat Biocon?
Unlock access to Bharat Biocon's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bharat Biocon?
Unlock and access historical data on people associated with Bharat Biocon, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bharat Biocon, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bharat Biocon's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.